Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multianalyte profiling of serum cytokines for detection of pancreatic cancer.

Cancer biomarkers : section A of Disease markers·2006

Same author

Two-effective-source method for the calculation of in-air output at various source-to-detector distances in wedged fields.

Medical physics·1999

Same author

Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area.

British journal of obstetrics and gynaecology·1999

Same author

(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.

Journal of medicinal chemistry·1999

Same author

Expression analysis of multidrug resistance associated genes in neuroblastomas.

Oncology reports·1999

Same author

A random survey of the Cryptosporidium parvum genome.

Infection and immunity·1999

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Inflammatory signaling compromises cell responses to interferon alpha.

W-C Huangfu¹, J Qian, C Liu

¹Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

|June 14, 2011

Summary

Inflammation hinders interferon alpha/beta (IFNα/β) cancer therapy by degrading the IFN receptor. Inhibiting p38 kinase restores IFNα/β efficacy against melanoma, suggesting new therapeutic strategies.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Related Experiment Videos

Last Updated: Jun 1, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Area of Science:

Oncology
Immunology
Cell Biology

Background:

Interferon alpha (IFNα) and interferon beta (IFNβ) are crucial cytokines for treating melanoma and other cancers.
Despite their anti-tumorigenic effects, the clinical efficacy of IFNα/β is often limited.

Purpose of the Study:

To investigate how inflammatory signaling interferes with IFNα/β anti-tumor effects.
To identify molecular mechanisms underlying impaired IFNα/β responsiveness in melanoma.

Main Methods:

Investigated the role of inflammatory cytokines (e.g., IL-1) in modulating cellular responses to IFNα/β.
Examined the phosphorylation, ubiquitination, and degradation of the type I IFN receptor subunit IFNAR1.
Assessed the involvement of p38 protein kinase in IFNAR1 downregulation.
Correlated p38 kinase activation with IFNAR1 levels in clinical melanoma samples.
Evaluated the impact of p38 kinase inhibition on IFNα/β efficacy in vitro and in vivo.

Main Results:

Pro-inflammatory cytokines activate a pathway that leads to IFNAR1 degradation, thereby inhibiting IFNα/β signaling.
p38 protein kinase activity is essential for this IFNAR1 downregulation and the resulting inhibition of IFNα/β effects.
p38 kinase activation inversely correlates with IFNAR1 protein levels in melanoma specimens.
Inhibiting p38 kinase enhances the anti-proliferative effects of IFNα/β on melanoma cells both in vitro and in vivo.

Conclusions:

Inflammatory signaling, particularly through p38 kinase activation, impairs the effectiveness of IFNα/β cancer therapy by reducing IFNAR1 levels.
Targeting p38 kinase represents a promising strategy to overcome resistance and improve the therapeutic outcomes of IFNα/β treatments for melanoma and potentially other malignancies.